DTF降茶氟剂降茶氟初步研究

目的探讨DTF制剂降茶氟效果。方法在不同制茶方法程序中加入DTF制剂观察其降氟效果。结果在冲泡或煮沸(1.0g茶叶,200ml水量)沏茶中,0.2gDTF可使茶氟降低约60%,使茶水氟浓度由2.0～4.0mg/L降到1.0mg/L左右,茶液色、味、pH值无改变。结论DTF是1种有效的降茶氟剂。     

茶水提取物和茶多酚抑制诱变的类型及其机制

目的 :研究茶水提取物和茶多酚的去突变特征和机制 ,鉴别茶和茶多酚去突变的量效关系和抑菌关系 ,了解去突变剂与直接诱变剂(1_NP)、间接(Trp_P_1)诱变剂的抗突变作用方式和抑制效果。 方法 :用细胞外抑制诱变试验和改进型两次活化的Ames试验方法。 结果 :茶水提取物和与其相关的儿茶素等都存在非抑菌性的去突变效果 ,其中表没食子儿茶素没食子酸酯(EGCG)和茶黄素(TF)的效果最好。抗突变试验结果表明 ,茶水提取物对Trp_P_1( +S9)有显著的抗突变性 ,与Trp_P_1的混合液在非代谢活性条件时无诱变性 ;茶水提取物对1_NP( -S9)也有抑制活性 ,但比对Trp_P_1的抑制活性低(P<0.01) ,与1_NP混合物经代谢活化后有诱变性 ,且与非代谢活化的抗突变结果呈较高的相关性(r= -0.9694)。 结论 :茶多酚能抑制间接诱变剂的前体形成 ,也有对直接诱变剂构成阻断剂的作用 ,但是在阻断具有强氧化性的诱变剂时可能形成不稳定的结合物或不安全的结构物。     

茶色素对冠心病及高血压病病人血小板功能的影响

目的：探索茶色素对冠心病、高血压病病人血小板功能的影响。方法：冠心病病人３６例（男性２１例，女性１５例；年龄６４±ｓ４ａ）；高血压病病人３０例（男性１８例，女性１２例；年龄５８±８ａ）。采用茶色素２５０ｍｇ，ｐｏ，ｔｉｄ，３０ｄ为一个疗程。结果：治疗后ＴＸＢ２下降，６－ｋｅｔｏ－ＰＧＰ１α上升，ＴＸＢ２／６－ｋｅｔｏ－ＰＧＦ１α比值下降（Ｐ＜０．０１或Ｐ＜０．０５），ＧＭＰ－１４０下降（Ｐ＜０．０５），ＰａｇＴ，ＰａｄＴ下降（Ｐ＜０．０５）。结论：茶色素具有降低血小板表面活性作用，抑制血小板聚集和粘附，抗血栓形成，改善微循环，对冠心病和高血压病病人起到积极的防治作用。     

茶叶多糖的研究进展

茶叶多糖是一种复合杂多糖，具有许多生物活性。作者系统地介绍了茶叶多糖的提取、分离、纯化、纯度鉴定及相对分子质量测定的方法，以及其含量和组成、理化性质、化学结构及空间构象、生物活性等方面的研究进展，并对上述方法及研究进展进行了分析和评述。     

茶叶中微量锰的新催化光度法测定

利用于氨三乙酸存在下，锰（Ⅱ）对高碘酸钾氧化二甲苯蓝ＦＦ的催化效应，建立了一个新的测定微量锰的动力学分光光度法。该法检出限为６×１０￣（－２）ｎｇ·ｍｌ￣（－１），线性范围为０．２～８．０ｎｇ·２．５ｍｌ￣（－１），常见离子基本不干扰测定。用于直接测定健齿茶和茉莉花茶中的锰含量，结果发现，锰含量分别为２２１４μｇ·ｇ￣（－１）及６４８μｇ·ｇ￣（－１）。此法简便易行，灵敏度高。     

绿茶及绿茶多酚抗羟自由基诱导的大鼠肝脂质过氧化作用

本研究采用Ｆｅ２＋，Ｈ２Ｏ２反应生成ＯＨ·诱导大鼠离体肝脏脂质过氧化反应体系，用ＧＴ和ＧＴＰ作为抗氧化剂观察对肝脂质过氧化的阻抑作用。随ＧＴ和ＧＴＰ浓度的升高对ＭＤＡ的抑制率分别为０．７７４～０．８９２，０．８１４～０．９７６，浓度与ＭＤＡ之间存在剂量效应关系。     

苏乐康等抑制细胞转化能力及其机制的探讨

研究了苏乐康、绿茶提取物对~(60)钴γ射线和雌性激素联合诱发叙利亚金黄地鼠胚胎细胞恶性转化的抑制能力,并用脉冲辐解技术,对其抑制机制进行初步探讨。实验结果表明,苏乐康、绿茶提取物对γ射线和雌性激素联合诱发的金黄地鼠胚胎细胞恶性转化的抑制率分别为70.15％(P<0.05)和81.59％(P<0.05),它们的这种抑制能力与其清除超氧阴离子的能力有关,     

茶多酚口含片中总儿茶素的含量测定

在酸性介质中对香英兰素与儿茶素的显色反应进行了研究，改进了反应条件，以５０６ｎｍ为测定波长，测定ＴＰ口含片中儿茶素的含量，线性范围７．５８μｇ～５３．０５μｇ（ｒ＝０．９９９８），回收率９７．９７％，ＲＳＤ１．８５％，认为改良法简便，灵敏，口含片辅料无干扰，可用于原料的药和制剂的含量分析。     

Curcumin,Quercetin, Catechins and Metabolic Diseases: The Role of Gut Microbiota

Polyphenols (PPs) are the naturally occurring bioactive components in fruits and vegetables, and they are the most abundant antioxidant in the human diet. Studies are suggesting that ingestion of PPs might be helpful to ameliorate metabolic syndromes that may contribute in the prevention of several chronic disorders like diabetes, obesity, hypertension, and colon cancer. PPs have structural diversity which impacts their bioavailability as they accumulate in the large intestine and are extensively metabolized through gut microbiota (GM). Intestinal microbiota transforms PPs into their metabolites to make them bioactive. Interestingly, not only GM act on PPs to metabolize them but PPs also modulate the composition of GM. Thus, change in GM from pathogenic to beneficial ones may be helpful to ameliorate gut health and associated diseases. However, to overcome the low bioavailability of PPs, various approaches have been developed to improve their solubility and transportation through the gut. In this review, we present evidence supporting the structural changes that occur after metabolic reactions in PPs (curcumin, quercetin, and catechins) and their effect on GM composition that leads to improving overall gut health and helping to ameliorate metabolic disorders.     

Proanthocyanidins and Flavan-3-ols in the Prevention and Treatment of Periodontitis—Immunomodulatory Effects,Animal and Clinical Studies

This paper continues the systematic review on proanthocyanidins and flavan-3-ols in the prevention and treatment of periodontal disease and covers the immunomodulatory effects, and animal- and clinical studies, while the other part discussed the direct antibacterial properties. Inflammation as a major response of the periodontal tissues attacked by pathogenic microbes can significantly exacerbate the condition. However, the bidirectional activity of phytochemicals that simultaneously inhibit bacterial proliferation and proinflammatory signaling can provide a substantial alleviation of both cause and symptoms. The modulatory effects on various aspects of inflammatory and overall immune response are covered, including confirmed and postulated mechanisms of action, structure activity relationships and molecular targets. Further, the clinical relevance of flavan-3-ols and available outcomes from clinical studies is analyzed and discussed. Among the numerous natural sources of flavan-3-ols and proanthocyanidins the most promising are, similarly to antibacterial properties, constituents of various foods, such as fruits of Vaccinium species, tea leaves, grape seeds, and tannin-rich medicinal herbs. Despite a vast amount of in vitro and cell-based evidence of immunomodulatory there are still only a few animal and clinical studies. Most of the reports, regardless of the used model, indicated the efficiency of these phytochemicals from cranberries and other Vaccinium species and tea extracts (green or black). Other sources such as grape seeds and traditional medicinal plants, were seldom. In conclusion, the potential of flavan-3-ols and their derivatives in prevention and alleviation of periodontal disease is remarkable but clinical evidence is urgently needed for issuing credible dietary recommendation and complementary treatments.